Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Lack of angiotensin II–facilitated erythropoiesis causes anemia in angiotensin-converting enzyme–deficient mice
Justin Cole, … , Pierre Corvol, Kenneth E. Bernstein
Justin Cole, … , Pierre Corvol, Kenneth E. Bernstein
Published December 1, 2000
Citation Information: J Clin Invest. 2000;106(11):1391-1398. https://doi.org/10.1172/JCI10557.
View: Text | PDF
Article Article has an altmetric score of 1

Lack of angiotensin II–facilitated erythropoiesis causes anemia in angiotensin-converting enzyme–deficient mice

  • Text
  • PDF
Abstract

While nephrologists often observe reduced hematocrit associated with inhibitors of angiotensin-converting enzyme (ACE), the basis for this effect is not well understood. We now report that two strains of ACE knockout mice have a normocytic anemia associated with elevated plasma erythropoietin levels. 51Cr labeling of red cells showed that the knockout mice have a normal total blood volume but a reduced red cell mass. ACE knockout mice, which lack tissue ACE, are anemic despite having normal renal function. These mice have increased plasma levels of the peptide acetyl-SDKP, a possible stem cell suppressor. However, they also show low plasma levels of angiotensin II. Infusion of angiotensin II for 2 weeks increased hematocrit to near normal levels. These data suggest that angiotensin II facilitates erythropoiesis, a conclusion with implications for the management of chronically ill patients on inhibitors of the renin-angiotensin system.

Authors

Justin Cole, Dilek Ertoy, Hsinchen Lin, Roy L. Sutliff, Eric Ezan, Tham T. Guyene, Mario Capecchi, Pierre Corvol, Kenneth E. Bernstein

×

Total citations by year

Year: 2024 2023 2022 2021 2020 2018 2017 2016 2015 2014 2013 2012 2011 2009 2008 2006 2005 2003 Total
Citations: 5 3 4 2 2 2 1 2 3 2 3 2 2 2 2 1 2 2 42
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (42)

Title and authors Publication Year
Genetic Variations Related to Angiotensin II Production and Risk for Basal Cell Carcinoma.
Gintoni I, Mastrogeorgiou M, Papakosta V, Vassiliou S, Yapijakis C
Biochemical Genetics 2024
Hypertension Increases Susceptibility to Experimental Malaria in Mice
Kandalgaonkar MR, Yeoh BS, Joe B, Schmidt NW, Vijay-Kumar M, Saha P
2024
Cholecystokinin B receptor agonists alleviates anterograde amnesia in cholecystokinin-deficient and aged Alzheimer's disease mice.
Zhang N, Sui Y, Jendrichovsky P, Feng H, Shi H, Zhang X, Xu S, Sun W, Zhang H, Chen X, Tortorella MD, He J
Alzheimer's research & therapy 2024
The Prognostic Role of RDW in Hospitalized Heart Failure Patients with and Without Chronic Kidney Disease
Giamouzis G, Kourek C, Magouliotis DE, Briasoulis A, Zakynthinos GE, Sawafta A, Iakovis N, Afxonidis G, Spiliopoulos K, Triposkiadis F, Athanasiou T, Skoularigis J, Xanthopoulos A
Journal of Clinical Medicine 2024
Prognostic Impact of the Ratio of Hemoglobin to Red Blood Cell Distribution Width in Patients after Acute Decompensated Heart Failure
Kanzaki Y, Minamisawa M, Motoki H, Suzuki S, Okuma Y, Kanai M, Machida K, Kimura K, Ueki Y, Yoshie K, Oguchi Y, Kato T, Saigusa T, Ebisawa S, Okada A, Kuwahara K
Internal Medicine 2024
Red blood cell distribution width/platelet ratio on admission as a predictor for in-hospital mortality in patients with acute myocardial infarction: a retrospective analysis from MIMIC-IV Database
Yao H, Lian L, Zheng R, Chen C
BMC Anesthesiology 2023
Progress in the Detection of Erythropoietin in Blood, Urine, and Tissue
Yasuoka Y, Izumi Y, Sands JM, Kawahara K, Nonoguchi H
Molecules (Basel, Switzerland) 2023
Incorporating inflammatory biomarkers into a prognostic risk score in patients with non-ischemic heart failure: a machine learning approach
Feng J, Zhao X, Huang B, Huang L, Wu Y, Wang J, Guan J, Li X, Zhang Y, Zhang J
Frontiers in immunology 2023
Assessment of ACE1 variants and ACE1/ACE2 expression in COVID-19 patients
M Akbari, M Taheri, G Mehrpoor, S Eslami, BM Hussen, S Ghafouri-Fard, N Arefian
Vascular Pharmacology 2022
Red Blood Cell Distribution Width in Heart Failure: Pathophysiology, Prognostic Role, Controversies and Dilemmas.
Xanthopoulos A, Giamouzis G, Dimos A, Skoularigki E, Starling RC, Skoularigis J, Triposkiadis F
Journal of Clinical Medicine 2022
Administration of α-Klotho Does Not Rescue Renal Anemia in Mice.
Park MY, Le Henaff C, Sitara D
Frontiers in Pediatrics 2022
Structural basis for the inhibition of human angiotensin-1 converting enzyme by fosinoprilat.
Cozier GE, Newby EC, Schwager SLU, Isaac RE, Sturrock ED, Acharya KR
The FEBS journal 2022
Discontinuation of the renin–angiotensin system inhibitors improves erythropoiesis in patients with lower-risk myelodysplastic syndromes
G Pavlidis, SG Papageorgiou, E Bazani, A Bouchla, E Glezou, K Gkontopoulos, T Thomopoulos, V Pappa, DV Vlahakos
Therapeutic Advances in Hematology 2021
Effects of Angiotensin II on Erythropoietin Production in the Kidney and Liver
Y Yasuoka, Y Izumi, T Fukuyama, H Inoue, T Oshima, T Yamazaki, T Uematsu, N Kobayashi, Y Shimada, Y Nagaba, M Mukoyama, Y Sato, JM Sands, K Kawahara, H Nonoguchi
Molecules (Basel, Switzerland) 2021
Targeting Angiotensin-Converting Enzyme-2/Angiotensin-(1-7)/Mas Receptor Axis in the Vascular Progenitor Cells for Cardiovascular Diseases
YP Jarajapu
Molecular pharmacology 2020
Angiotensin‐converting enzyme open for business: structural insights into the subdomain dynamics
GE Cozier, L Lubbe, ED Sturrock, KR Acharya
The FEBS journal 2020
Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia
R Agoro, A Montagna, R Goetz, O Aligbe, G Singh, LM Coe, M Mohammadi, S Rivella, D Sitara
The FASEB Journal 2018
Circulating Fibroblast Growth Factor-23 Levels are Associated with an Increased Risk of Anemia Development in Patients with Nondialysis Chronic Kidney Disease
KH Nam, H Kim, SY An, M Lee, MU Cha, JT Park, TH Yoo, KB Lee, YH Kim, SA Sung, J Lee, SW Kang, KH Choi, C Ahn, SH Han
Scientific Reports 2018
Angiotensin-converting enzyme affects the presentation of MHC class II antigens
T Zhao, KE Bernstein, J Fang, XZ Shen
Laboratory Investigation 2017
High Fibroblast Growth Factor 23 Levels Associated With Low Hemoglobin Levels in Patients With Chronic Kidney Disease Stages 3 and 4:
MH Tsai, JG Leu, YW Fang, HH Liou
Medicine 2016
Haematopoietic effects of Angelica sinensis root cap polysaccharides against lisinopril-induced anaemia in albino rats
F Younas, B Aslam, F Muhammad, M Mohsin, A Raza, MN Faisal, SU Hassan, W Majeed
Pharmaceutical Biology 2016
Resistance of dialyzed patients to erythropoietin
MT Alves, SS Vilaça, MG Carvalho, AP Fernandes, LM Dusse, KB Gomes
Revista Brasileira de Hematologia e Hemoterapia 2015
Erythropoiesis and Blood Pressure Are Regulated via AT1 Receptor by Distinctive Pathways
H Kato, J Ishida, T Matsusaka, T Ishimaru, K Tanimoto, F Sugiyama, K Yagami, M Nangaku, A Fukamizu, M Bader
PloS one 2015
Relationship between red cell distribution width and long-term mortality in patients with non-ST elevation acute coronary syndrome
A Bekler, E Tenekecioglu, G Erbag, A Temiz, B Altun, A Barutcu, E Gazi, F Gunes, M Yilmaz
The Anatolian Journal of Cardiology 2015
ACE Overexpression in Myelomonocytic Cells: Effect on a Mouse Model of Alzheimer’s Disease
M Koronyo-Hamaoui, K Shah, Y Koronyo, E Bernstein, JF Giani, T Janjulia, KL Black, PD Shi, RA Gonzalez-Villalobos, S Fuchs, XZ Shen, KE Bernstein
Current Hypertension Reports 2014
Angiotensin-converting enzyme overexpression in myelocytes enhances the immune response
KE Bernstein, RA Gonzalez-Villalobos, JF Giani, K Shah, E Bernstein, T Janjulia, Y Koronyo, PD Shi, M Koronyo-Hamaoui, S Fuchs, XZ Shen
Biological Chemistry 2014
Contribution of the Local RAS to Hematopoietic Function: A Novel Therapeutic Target
KE Rodgers, GS Dizerega
Frontiers in Endocrinology 2013
Chronic vasodilation increases renal medullary PDE5A and  -ENaC through independent renin-angiotensin-aldosterone system pathways
CA West, S Shaw, JM Sasser, A Fekete, T Alexander, MW Cunningham, SM Masilamani, C Baylis
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2013
Contributions of Leukocyte Angiotensin-Converting Enzyme to Development of Atherosclerosis
X Chen, H Lu, M Zhao, K Tashiro, LA Cassis, A Daugherty
Arteriosclerosis, thrombosis, and vascular biology 2013
Nontraditional Roles of Angiotensin-Converting Enzyme
XZ Shen, FS Ong, EA Bernstein, T Janjulia, WL Blackwell, KH Shah, BL Taylor, RA Gonzalez-Villalobos, S Fuchs, KE Bernstein
Hypertension 2012
A Modern Understanding of the Traditional and Nontraditional Biological Functions of Angiotensin-Converting Enzyme
KE Bernstein, FS Ong, WL Blackwell, KH Shah, JF Giani, RA Gonzalez-Villalobos, XZ Shen, S Fuchs, RM Touyz
Pharmacological reviews 2012
Angiotensin-converting enzyme is required for normal myelopoiesis
C Lin, V Datta, D Okwan-Duodu, X Chen, S Fuchs, R Alsabeh, S Billet, KE Bernstein, XZ Shen
The FASEB Journal 2011
The carboxypeptidase angiotensin converting enzyme (ACE) shapes the MHC class I peptide repertoire
XZ Shen, S Billet, C Lin, D Okwan-Duodu, X Chen, AE Lukacher, KE Bernstein
Nature Immunology 2011
A role for the renin-angiotensin system in hematopoiesis
TS Park, ET Zambidis
Haematologica 2009
Preservation of Intracellular Renin Expression Is Insufficient to Compensate for Genetic Loss of Secreted Renin
D Xu, GR Borges, JL Grobe, CJ Pelham, B Yang, CD Sigmund
Hypertension 2009
Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance
AP Jayasooriya, ML Mathai, LL Walker, DP Begg, DA Denton, D Cameron-Smith, GF Egan, MJ McKinley, PD Rodger, AJ Sinclair, JD Wark, HS Weisinger, M Jois, RS Weisinger
Proceedings of the National Academy of Sciences 2008
Expression of angiotensin-converting enzyme changes major histocompatibility complex class I peptide presentation by modifying C termini of peptide precursors
XZ Shen, AE Lukacher, S Billet, IR Williams, KE Bernstein
The Journal of biological chemistry 2008
Renale Anämie — eine wichtige Folgeerkrankung der Niereninsuffizienz
C Mayer, H Achenbach, M Stumvoll, GM Fiedler
Der Internist 2006
Effect of angiotensin II on cord blood CD34+ cells expansionin vitro
P Cheng, Z Ping, M Yanping, H Zongbo
Journal of Huazhong University of Science and Technology [Medical Sciences] 2005
Anemia in heart failure-A concise review
S Vasu, P Kelly, WE Lawson
Clinical Cardiology 2005
Do alterations of endogenous angiotensin II levels regulate erythropoietin production in humans?
S Freudenthaler, P Benöhr, A Grenz, T Selzer, T Schmidt, K Mörike, H Osswald, CH Gleiter
British Journal of Clinical Pharmacology 2003
Newer Approaches to Genetic Modeling in Mice : Tissue-Specific Protein Expression as Studied Using Angiotensin-Converting Enzyme (ACE)
Xiao HD, Fuchs S, Frenzel K, Cole JM, Bernstein KE
The American Journal of Pathology 2003

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 1 X users
36 readers on Mendeley
See more details